Overview
Youngjin Ha is a partner of Bae, Kim & Lee LLC, and her practice focuses on all the matters involving securities and finance such as capital market, corporate finance, acquisition finance, financial regulation, securitization, structured finance, and project finance.
Ms. Ha also represented and advised clients on securities offering, KRX IPO of domestic and international companies, private equity investment, foreign investment, acquisition finance and project financing accompanying major M&As and projects, and financial dispute matters.
Ms. Ha graduated with top honors from Korea University Law School in 2012 and was admitted to the Korean Bar in the same year. After joining BKL, she earned an LL.M. from Harvard Law School and was admitted to the New York Bar in the same year.
Related Practices
Representative Experience
2019-2020
Visiting Attorney, Greenberg Traurig LLP, Seoul
2012-Present
Bae, Kim & Lee LLC
See More
2022-Present
Member, Small Enterprise Credit Risk Management Committee, Korea Federation of Small and Medium Business
2022-2023
Adjunct Professor, Korea University School of Law
Representative Matters
KRX IPOs by domestic/foreign companies (Kakao Bank, Krafton, Hyundai Heavy Industries, Kakao Games, Samsung Biologics, Doosan Bobcat, Celltrion Healthcare, Englewood Lab, Access Bio. Inc., Organic Tea Cosmetics, GRT, etc.)
Debt issuance transactions of Korean government, domestic/foreign companies and public institutions
Advised private equity funds on their acquisition financing accompanied in M&A transactions (i.e., Affinity Equity Partners on its acquisition of LocknLock, Shinhan Financial Group and recapitalization of SSG.com investment, Credit Suisse as lender for Carlyle's share acquisition of KB Financial Group, Carlyle Group on its acquisition of Twosome Place etc.)
Advised Kakao Corp. and Hanwha Chemical on the issuance of GDR and listing on the Singapore Exchange
Advised on cross-border and overseas alternative investment transaction (Portfolio investment in LA logistics center, mezzanine loan investment in U.S. hotel, etc.)
KRX IPOs by domestic/foreign companies (Kakao Bank, Krafton, Hyundai Heavy Industries, Kakao Games, Samsung Biologics, Doosan Bobcat, Celltrion Healthcare, Englewood Lab, Access Bio. Inc., Organic Tea Cosmetics, GRT, etc.)
Debt issuance transactions of Korean government, domestic/foreign companies and public institutions
Advised private equity funds on their acquisition financing accompanied in M&A transactions (i.e., Affinity Equity Partners on its acquisition of LocknLock, Shinhan Financial Group and recapitalization of SSG.com investment, Credit Suisse as lender for Carlyle's share acquisition of KB Financial Group, Carlyle Group on its acquisition of Twosome Place etc.)
Advised Kakao Corp. and Hanwha Chemical on the issuance of GDR and listing on the Singapore Exchange
Advised on cross-border and overseas alternative investment transaction (Portfolio investment in LA logistics center, mezzanine loan investment in U.S. hotel, etc.)
Advised on financial dispute matters relating to investments involving private funds, derivative-linked securities, specific fund trust and others
Advised various clients on NPL transaction, asset securitization, project financing and other structured financing matters
Education
2019
Harvard Law School (LL.M.)
2012
Korea University School of Law (J.D., summa cum laude)
2009
Korea Advanced Institute of Science and Technology (KAIST) (B.S.)
Selected Activities
Publications
COVID-19 and issues on financial contracts, BFL No. 103 (Co-author, Seoul National University Center for Financial Law, 2020)
Awards
IFLR 1000 - Leading Lawyer (2022-2023)
IFLR Asia-Pacific Awards - Rising Stars (2021)
Qualifications
2023
New York
2012
Korea
Awards and Recognition
-
IFLR1000 (2023) Leading Lawyer
-
IFLR1000 (2022) Leading Lawyer
-
IFLR Asia-Pacific Awards 2021 - Rising Stars
Related Content
View morePractice Areas
Awards and Recognition
-
IFLR1000 (2023) Leading Lawyer
-
IFLR1000 (2022) Leading Lawyer
-
IFLR Asia-Pacific Awards 2021 - Rising Stars
